Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin
The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.
Abstract
Engineered Salmonella secreting heterologous bacterial flagellin suppress tumor growth by activating intratumoral macrophages.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“with intratumoral or intravenous injection often leading to ~10,000-fold accumulation in tumors relative to matched liver, spleen, and lung tissues (152, 153).”
From The microbiome and human cancer (2021) · cites this paper as [152]
Citations
Cites
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828 · cited 1×
“INTRODUCTION Abnormal blood vessels and hypoxic and necrotic regions are universal features of solid tumors (1, 2).”
BackgroundKigerl, K. A., Gensel, J. C., Ankeny, D. P., Alexander, J. K., Donnelly, D. J., & Popovich, P. G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3257-09.2009 · Cited by 2,130 · cited 1×
“The engrafted MC38 tumor tissues were removed from C57BL/6 WT mice 24 hours after induction of FlaB and triple-stained with CD45, F4/80, and CD206 (to detect M2-type macrophages) or with CD45, F4/80, and CD86 (to detect M1-type macrophages) (32, 33).”
MethodTargeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80596-8 · Cited by 2,041 · cited 1×
“TLR4, TLR5, and MyD88 knockout mice with a C57BL/6 genetic background were described previously (47, 48).”
MethodMolecular Mechanisms That Influence the Macrophage M1–M2 Polarization Balance
Wang, N., Liang, H., & Zen, K. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00614 · Cited by 1,980 · cited 10×
“The in vitro stimulation of cancer cells with FlaB did not increase phosphorylation of NF-kB p65 (fig.”
BackgroundInfluentialThe Isolation and Characterization of Murine Macrophages
Zhang, X., Goncalves, R., & Mosser, D. M. (2008) · Current Protocols in Immunology · doi:10.1002/0471142735.im1401s83 · Cited by 1,536 · cited 1×
“Cell preparation and FACS analysis Peritoneal macrophages were isolated from specific pathogen–free C57BL/6 male mice, as described previously (50).”
MethodToll-like receptors and cancer
Rakoff-Nahoum, S., & Medzhitov, R. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2541 · Cited by 925
Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers
Saito, T., Nishikawa, H., Wada, H., Nagano, Y., Sugiyama, D., Atarashi, K., Maeda, Y., Hamaguchi, M., Ohkura, N., Sato, E., et al. (2016) · Nature Medicine · doi:10.1038/nm.4086 · Cited by 871 · cited 1×
“Because the background signals in experimental groupswere different, whichmay be due to different degrees of cell injury resulting from the different modes of treatment (PBS, empty Salmonella, and FlaB-secreting Salmonella), we adjusted gating parameters for the FACS analysis of different groups (51, 52).”
MethodTherapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
Kanzler, H., Barrat, F. J., Hessel, E. M., & Coffman, R. L. (2007) · Nature Medicine · doi:10.1038/nm1589 · Cited by 869 · cited 1×
“Because of accumulating reports that activating various TLRs resulted in antitumor effects (31, 37–41), many TLRspecific agonists are currently being investigated for tumor immunotherapy (37).”
BackgroundBiswas, S. K. (2006) · Blood · doi:10.1182/blood-2005-01-0428 · Cited by 696
Toso, J. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.142 · Cited by 614 · cited 1×
“VNP20009, an attenuated strainof Salmonella typhimurium with purI and msbB gene deletions, was safely administered to patients with metastatic melanoma and renal cell carcinoma in a phase 1 study, where substantial tumor colonization was observed (11, 12).”
Research works printed but not linked: 1
- 10.1200/jco.2002.20.1.142 · DOI · Paper page
Cited by
Items 201–300 of 627
Deimmunization of flagellin adjuvant for clinical application
Rhee, J. H., Khim, K., Puth, S., Choi, Y., & Lee, S. E. (2023) · Current Opinion in Virology · doi:10.1016/j.coviro.2023.101330 · Cited by 36
Self-citationDevelopment of a TNF-α-mediated Trojan Horse for bacteria-based cancer therapy
Hu, C.-W., Chang, Y.-C., Liu, C.-H., Yu, Y., & Mou, Y. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.04.008 · Cited by 36
Harnessing Bacterial Agents to Modulate the Tumor Microenvironment and Enhance Cancer Immunotherapy
Thomas, C. J., Delgado, K., Sawant, K., Roy, J., Gupta, U., Song, C. S., Poojary, R., de Figueiredo, P., & Song, J. J. (2024) · Cancers · doi:10.3390/cancers16223810 · Cited by 35
Engineered bacteria: Strategies and applications in cancer immunotherapy
Zhang, S., Li, R., Xu, Y., Liu, R., Sun, D., & Dai, Z. (2024) · Fundamental Research · doi:10.1016/j.fmre.2024.11.001 · Cited by 35
“The signaling sequence directs the secretion of functional proteins into the tumor extracellular matrix, releasing the therapeutic payload [ 131 , 132 ].”
Designing live bacterial therapeutics for cancer
Lee, J., McClure, S., Weichselbaum, R. R., & Mimee, M. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115579 · Cited by 35
Salmonella Overcomes Drug Resistance in Tumor through P-glycoprotein Downregulation
Yang, C., Chang, W., Lin, S., Chen, M., & Lee, C. (2018) · International Journal of Medical Sciences · doi:10.7150/ijms.23285 · Cited by 35
“In addition, Salmonella cannot disperse throughout the tumor and this is the disadvantage for its use as an anticancer agent [28].”
BackgroundEngineering bacteria for cancer therapy
Harimoto, T., & Danino, T. (2019) · Emerging Topics in Life Sciences · doi:10.1042/etls20190096 · Cited by 35
Engineering microbial diagnostics and therapeutics with smart control
Amrofell, M. B., Rottinghaus, A. G., & Moon, T. S. (2020) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2020.05.006 · Cited by 35
“For example, attenuated Salmonella typhimurium (aSt) was engineered to express a heterologous flagellin in the presence of arabinose [20].”
BackgroundNew technologies in developing recombinant‐attenuated bacteria for cancer therapy
Liang, K., Liu, Q., & Kong, Q. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27596 · Cited by 35
“Moreover, Min et al. (2008) showed that engineered Salmonella secreting Vibrio vulnificus flagellin B effectively suppressed tumor growth and metastasis, and prolonged survival in mouse model (J. H. Zheng et al., 2017).”
BackgroundMónaco, A., Chilibroste, S., Yim, L., Chabalgoity, J. A., & Moreno, M. (2022) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-022-03148-x · Cited by 35
Engineering versatile nano-bacteria hybrids for efficient tumor therapy
Wang, W., Yu, W., Li, G., Huang, H., Song, X., Yu, L., & Chen, Y. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215178 · Cited by 35
TLR5 agonists enhance anti-tumor immunity and overcome resistance to immune checkpoint therapy
González, C., Williamson, S. L., Gammon, S. T., Glazer, S. E., Rhee, J. H., & Piwnica-Worms, D. R. (2023) · Communications Biology · doi:10.1038/s42003-022-04403-8 · Cited by 34
Self-citationNeutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
Yam, A. O. W., Bailey, J., Lin, F., Jakovija, A., Youlten, S. E., Counoupas, C., Gunzer, M., Bald, T., Woodruff, T. M., Triccas, J. A., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-21-4025 · Cited by 34
A Review of the Use of Native and Engineered Probiotics for Colorectal Cancer Therapy
Han, H., Zhang, Y., Tang, H., Zhou, T., & Khan, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073896 · Cited by 33
Yarahmadi, A., Zare, M. A., Aghayari, M., Afkhami, H., & Jafari, G. A. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01622-w · Cited by 33
Xu, X., Ding, Y., Dong, Y., Yuan, H., Xia, P., Qu, C., Ma, J., Wang, H., Zhang, X., Zhao, L., et al. (2024) · Advanced Science · doi:10.1002/advs.202401905 · Cited by 33
Brevi, A., Cogrossi, L. L., Lorenzoni, M., Mattorre, B., & Bellone, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.845422 · Cited by 32
Recent Update on Bacteria as a Delivery Carrier in Cancer Therapy: From Evil to Allies
Pandey, M., Choudhury, H., Vijayagomaran, P. A. P., Lian, P. N. P., Ning, T. J., Ng Zing, W. A. I., Xian-Zhuang, N., Er, C. L., Rahmah, N. S. N., Kamaruzzaman, N. D. B., et al. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03240-y · Cited by 32
Bacterial Drug Delivery Systems for Cancer Therapy: “Why” and “How”
Zhao, X., Xie, N., Zhang, H., Zhou, W., & Ding, J. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15092214 · Cited by 32
“typhimurium expressing flagellin promoted the M2–M1 transition of macrophages and increased the level of nitric oxide in tumors through the synergistic effect with TLR4 and TLR5 signaling pathways [64].”
BackgroundPerspectives on Oncolytic Salmonella in Cancer Immunotherapy—A Promising Strategy
Wang, D., Wei, X., Kalvakolanu, D. V., Guo, B., & Zhang, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.615930 · Cited by 32
“Besides, flagellin diminished the numbers of Treg cells in the TME (46, 47).”
BackgroundGao, S., Jung, J., Lin, S., Jang, A.-Y., Zhi, Y., Ahn, K. B., Ji, H.-J., Lim, J. H., Guo, H., Choy, H. E., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-60396-6 · Cited by 31
Self-citationSu, S., Munganga, B. P., Du, F., Yu, J., Li, J., Yu, F. D., Wang, M., He, X., Li, X., Bouzoualegh, R., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.565267 · Cited by 31
Bladder cancer-associated microbiota: Recent advances and future perspectives
Zhang, W., Yang, F., Mao, S., Wang, R., Chen, H., Ran, Y., Liu, S., Wu, P., Yan, Y., Li, W., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13012 · Cited by 31
Molecular principles of tissue invasion and metastasis
Dhanisha, S. S., & Guruvayoorappan, C. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00348.2022 · Cited by 31
Phototrophic purple bacteria as optoacoustic in vivo reporters of macrophage activity
Peters, L., Weidenfeld, I., Klemm, U., Loeschcke, A., Weihmann, R., Jaeger, K., Drepper, T., Ntziachristos, V., & Stiel, A. C. (2019) · Nature Communications · doi:10.1038/s41467-019-09081-5 · Cited by 31
Recent systems biology approaches for probiotics use in health aspects: a review
Yadav, M., & Shukla, P. (2019) · 3 Biotech · doi:10.1007/s13205-019-1980-5 · Cited by 31
Kim, S., Kim, Y., Lee, S., Kim, Y., Jeon, B., Kim, H., & Park, H. (2022) · Cancers · doi:10.3390/cancers14174083 · Cited by 30
Self-citationRecent advances in biomimetic strategies for the immunotherapy of glioblastoma
You, H., Geng, S., Li, S., Imani, M., Brambilla, D., Sun, T., & Jiang, C. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122694 · Cited by 30
Interactions between the tumor microbiota and breast cancer
Guo, H. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1499203 · Cited by 29
Niu, L., Deng, Z., Jin, Y., Guan, N., & Ye, H. (2025) · Protein & Cell · doi:10.1093/procel/pwaf085 · Cited by 29
The intratumoural microbiota in cancer: new insights from inside
An, Y., Zhang, W., Liu, T., Wang, B., & Cao, H. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188626 · Cited by 29
Puth, S., Verma, V., Hong, S. H., Tan, W., Lee, S. E., & Rhee, J. H. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121542 · Cited by 29
Self-citationIntratumoural microbiota: from theory to clinical application
Ji, H., Jiang, Z., Wei, C., Ma, Y., Zhao, J., Wang, F., Zhao, B., Wang, D., & Tang, D. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01134-z · Cited by 29
Advancements in synthetic biology-based bacterial cancer therapy: A modular design approach
Arboleda-García, A., Alarcon‐Ruiz, I., Boada-Acosta, L., Boada, Y., Vignoni, A., & Lewintre, E. J. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.104088 · Cited by 29
Nguyen, T. D., Le, H. D., Dang, G. C., Jung, H. S., Choi, Y., Khim, K., Kim, Y. I., Lee, S. E., & Rhee, J. H. (2025) · Nature Communications · doi:10.1038/s41467-025-58115-8 · Cited by 28
Self-citationEngineering Bacteria as Living Therapeutics in Cancer Therapy
Chen, J., Chen, J., Chen, Y., Yuan, W., Zhang, J., Wang, G., & Dai, Z. (2025) · Advanced Science · doi:10.1002/advs.202507820 · Cited by 28
Chen, T., Zhao, X., Ren, Y., Wang, Y., Tang, X., Tian, P., Wang, H., & Xin, H. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-9481-8 · Cited by 28
Microbial cancer therapeutics: A promising approach
Diwan, D., Cheng, L., Usmani, Z., Sharma, M., Holden, N. J., Willoughby, N. A., Sangwan, N. S., Baadhe, R. R., Liu, C., & Gupta, V. K. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.003 · Cited by 28
The microbiome, gastrointestinal cancer, and immunotherapy
Newsome, R. C., Yang, Y., & Jobin, C. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15742 · Cited by 28
Liu, X., Guo, Y., Sun, Y., Chen, Y., Tan, W., Min, J., & Zheng, J. H. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.914575 · Cited by 28
Self-citationNucleoside Diphosphate Kinase-3 ( NME3 ) Enhances TLR5-Induced NF κ B Activation
Flentie, K., González, C., Kocher, B. A., Wang, Y., Zhu, H., Marasa, J. C., & Piwnica-Worms, D. R. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0603 · Cited by 28
“We used either heatkilled Salmonella or flagellin derived from Salmonella as a TLR5 stimulus, whereas the other study (15) usedflagellin derived from Vibrio vulnificus.”
BackgroundMethodResultSun, Y., Guo, Y., Liu, X., Liu, J., Sun, H., Li, Z., Wen, M., Jiang, S., Tan, W., & Zheng, J. H. (2023) · Theranostics · doi:10.7150/thno.87340 · Cited by 27
“Furthermore, Δ ppGpp has been used alone or in combination with chemotherapy or radiotherapy for enhanced cancer treatments [28,29] and can serve as a protein expression vector or BMCT [30-32].”
Self-citationTargeted drug delivery therapies inspired by natural taxes
Nguyen, H. V., & Faivre, V. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.005 · Cited by 27
Salmonella cancer therapy metabolically disrupts tumours at the collateral cost of T cell immunity
Copland, A., Mackie, G. M., Scarfe, L., Jinks, E., Lecky, D. A. J., Gudgeon, N. H., McQuade, R., Lab), M. O. (., Barthel, M., Hardt, W., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00159-2 · Cited by 27
“…control is proportionally identical between wild-type (WT) mice and athymic nude/SCID mice after Salmonella treatment (Kaimala et al, 2014; Lin et al, 2021; Luo et al, 2001); indeed, many ef fi cacy studies are conducted in athymic mice with xenograft tumours (Zhao et al, 2005; Zheng et al, 2017).”
Ran, H., Yang, Y., Han, W., Liang, R., Zhu, D., Yuan, B., Xu, C., Li, D., Ren, J., Pan, H., et al. (2024) · Trends in biotechnology · doi:10.1016/j.tibtech.2024.11.018 · Cited by 26
Wang, Y., Xiao, S., Yu, W., Han, B. R., & Guo, G. F. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01766-3 · Cited by 26
“Conversely, the interplay between the tumor microbiome and host immunity is highly complex, with intratumoral bacteria employing multiple anticancer mechanisms [39, 67–70].”
Synergies of Systems Biology and Synthetic Biology in Human Microbiome Studies
Ezzamouri, B., Shoaie, S., & Ledesma‐Amaro, R. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.681982 · Cited by 26
Recent advances in bacterial therapeutics based on sense and response
Feng, Z., Wang, Y., Xu, H., Guo, Y., Xia, W., Zhao, C., Zhao, X., & Wu, J. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.09.015 · Cited by 26
Nobre, J. G., & Costa, D. A. (2022) · Frontiers in Gastroenterology · doi:10.3389/fgstr.2022.1020190 · Cited by 26
Ashu, E. E., Xu, J., & Yuan, Z. (2019) · Journal of Cancer · doi:10.7150/jca.31699 · Cited by 26
“(9-24) To facilitate BMCT research, we sought to answer the following questions in this paper: (1) what makes a bacterium a good BMCT candidate? (2) How would a good BMCT prospect be identified? (3) How can different BMCT candidates be compared? Building on previously published literature, we discuss key bacterial tra…”
BackgroundWang, W., Fan, J., Zhang, C., Huang, Y., Chen, Y., Fu, S., & Wu, J. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127668 · Cited by 25
Development of bacteria as diagnostics and therapeutics by genetic engineering
Lim, D., & Song, M. (2019) · The Journal of Microbiology · doi:10.1007/s12275-019-9105-8 · Cited by 25
Bacterial carrier-mediated drug delivery systems: a promising strategy in cancer therapy
Yan, S., Gan, Y., Xu, H., & Piao, H. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1526612 · Cited by 24
Systemic Delivery Strategies for Oncolytic Viruses: Advancing Targeted and Efficient Tumor Therapy
Xia, Y., Li, D., Yang, K., & Ou, X. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146900 · Cited by 24
“Zheng et al. [103] found that, three days after an intravenous injection of S. typhimurium, the number of bacteria at the tumor site reached 10 10 CFU/g, a quantity 10,000 times higher than that in normal tissues.”
Oral natural extracellular vesicles for biomedical applications: Advances and clinical perspectives
Guan, X., Zhu, M., Zhu, H., Wang, Q., Chen, J., Chen, Y., Mou, X., & Si, J. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.08.003 · Cited by 24
Xu, S., Zhang, T., Song, Y. N., Wang, M., Wu, R., Li, M., Wang, H., Xie, X., Chen, Q., Ma, X., et al. (2026) · Nature Biotechnology · doi:10.1038/s41587-026-03054-y · Cited by 24
Becerra-Báez, E. I., Meza-Toledo, S. E., Muñoz-López, P., Flores-Martínez, L. F., Fraga-Pérez, K., Magaño-Bocanegra, K. J., Juárez-Hernández, U., Mateos-Chávez, A. A., & Luría-Pérez, R. (2022) · Cancers · doi:10.3390/cancers14174224 · Cited by 24
Miao, Y., Wang, S., Zhang, B., & Liu, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1133238 · Cited by 24
Advances in Nanomaterials for Immunotherapeutic Improvement of Cancer Chemotherapy
Liu, J., Li, B., Li, L., Ming, X., & Xu, Z. P. (2024) · Small · doi:10.1002/smll.202403024 · Cited by 24
Zheng, L., Wang, H., Zhong, X., Lin, J. H., Shi, G., Bai, C., Yang, R., Huang, Z., Jiang, Y., Wei, J., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122809 · Cited by 24
A Microrobotic System Based on Engineered Bacteria for Targeted Self‐Driven Photodynamic Therapy
Jin, K., Yu, L., Zhang, Y., Niu, L., Huang, Y., Zhang, Y., & Wu, Y. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202414347 · Cited by 24
Dynamic Hydrogels: Adaptive Biomaterials for Engineering Tumor Microenvironment and Cancer Treatment
Wu, Y., Xiao, Y., Yin, B., & Wong, S. H. D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199502 · Cited by 24
“Encapsulating these formulations in hydrogels enhances local delivery and improves efficacy [101].”
Zhao, D., Feng, W., Kang, X., Li, H., Liu, F., Zheng, W., Li, G., & Wang, X. (2023) · Journal of Materials Chemistry B · doi:10.1039/d3tb00125c · Cited by 23
Current advances in bacteria‐based cancer immunotherapy
Guo, C., Liu, J., & Zhang, Y. (2023) · European Journal of Immunology · doi:10.1002/eji.202350778 · Cited by 23
Transforming bacterial pathogens into wonder tools in cancer immunotherapy
Senevirathne, A., Lloren, K. K. S., Aganja, R. P., Kwon, J., & Lee, J. H. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.01.029 · Cited by 22
Jameel, M., & Kwok, H. F. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.06.011 · Cited by 22
Nguyen, D.-H., You, S.-H., Vo, A.-T. N., Ngo, H. T.-T., Nguyen, K. V., Duong, M. T.-Q., Choy, H. E., Song, M., Hong, Y., & Min, J. (2021) · Molecular Imaging and Biology · doi:10.1007/s11307-021-01624-x · Cited by 22
Self-citationBacterial cancer therapy: A turning point for new paradigms
Vijayakumar, M., Kannappan, P., Tharmalingam, N., Bose, R. J., Madheswaran, T., & Ramasamy, M. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.03.007 · Cited by 22
Genetic Programming by Nitric Oxide-Sensing Gene Switch System in Tumor-Targeting Bacteria
Qin, Y., You, S.-H., Zhang, Y., Venu, A., Hong, Y., & Min, J. (2023) · Biosensors · doi:10.3390/bios13020266 · Cited by 22
Self-citationLiu, L., Chen, C., Xin, W., Li, Q., Han, C., & Hua, Z. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02335-5 · Cited by 22
Synthetic immunity by remote control
Gamboa, L., Zamat, A. H., & Kwong, G. A. (2020) · Theranostics · doi:10.7150/thno.41305 · Cited by 22
“Remarkably, recent studies have shown that certain strains of bacteria preferentially colonize and grow in tumors, thriving on the nutrients of the necrotic core while masked from immune surveillance by tumor-induced suppression [167-169].”
BackgroundPrecision strategies for cancer treatment by modifying the tumor-related bacteria
Lu, H., Wang, Q., Liu, W., Wen, Z., & Li, Y. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11491-9 · Cited by 22
Xu, H., Piao, L., Wu, Y., & Liu, X. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.996055 · Cited by 22
“A shift fromM2 toM1 is induced by BCI, which promotes tumor regression (Zheng et al., 2017).”
BackgroundIntratumoral microbiota remodeling of the tumor microenvironment impact solid tumor immunotherapy
Jia, J., Gao, W., Wang, C., Liu, L., Li, Y., Sun, Z., Yang, C., Chen, Y., Yu, H., & Cheng, Y. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08211-w · Cited by 21
“Salmonella -mediated β -galactosidase administration results in robust immune responses [133], whereas attenuated Listeria monocytogenes (Lm at -LLO) is effective in melanoma models as a drug delivery platform [134] (Fig.”
Engineered microorganism-based delivery systems for targeted cancer therapy: a narrative review.
Huang, X., Guo, H., Wang, L., & Shao, Z. (2022) · PubMed Central · doi:10.12336/biomatertransl.2022.03.004 · Cited by 21
Roe, J. M., Seely, K. D., Bussard, C. J., Martin, E. E., Mouw, E. G., Bayles, K. W., Hollingsworth, M. A., Brooks, A. E., & Dailey, K. M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15072004 · Cited by 22
The role of extratumoral and intratumoral microorganisms in cancer immunotherapy
Du, Y., Liu, L., Ma, W., Yan, W., Mao, W., Du, Y., Cui, K., Pu, Y., Li, Z., Sansonetti, P. J., et al. (2023) · The Innovation Life · doi:10.59717/j.xinn-life.2023.100016 · Cited by 21
Microbial Biogeography Along the Gastrointestinal Tract of a Red Panda
Zeng, Y., Zeng, D., Zhou, Y., Niu, L., Deng, J., Li, Y., Pu, Y., Lin, Y., Xu, S., Liu, Q., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01411 · Cited by 21
Wu, Y., Li, Q., Liu, Y., Li, Y., Chen, Y., Wu, X., & Liu, X. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120817 · Cited by 21
Wang, H., Zheng, L., Yang, C., Lin, J. H., Zhou, R., Liu, H., Dong, Y., Xu, X., Shi, G., Yang, J., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102191 · Cited by 20
Salmonella enterica and outer membrane vesicles are current and future options for cancer treatment
Jorge, G. P., Gontijo, M. T. P., & Brocchi, M. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1293351 · Cited by 20
Setting “cold” tumors on fire: Cancer therapy with live tumor-targeting bacteria
Manole, S., Nguyen, D.-H., Min, J.-J., Zhou, S., & Forbes, N. (2024) · Med · doi:10.1016/j.medj.2024.11.002 · Cited by 20
Self-citationReporter gene-based optoacoustic imaging of E. coli targeted colon cancer in vivo
Yun, M., You, S.-H., Nguyen, V. H., Prakash, J., Glasl, S., Gujrati, V., Choy, H. E., Stiel, A. C., Min, J., & Ntziachristos, V. (2021) · Scientific Reports · doi:10.1038/s41598-021-04047-4 · Cited by 20
Self-citationNontyphoidal Salmonella : a potential anticancer agent
Jazeela, K., Chakraborty, A., Karunasagar, I., & Deekshit, V. K. (2019) · Journal of Applied Microbiology · doi:10.1111/jam.14297 · Cited by 20
“Nevertheless, it should be noted that the studies by Zheng et al. (2017) sheds light on the usefulness of flagella in tumour regression only when the FlaB of V. vulnificus was overexpressed in tumour through Salmonella since FlaB is more potent than FliC of Salmonella in stimulating TLR5 signalling.”
BackgroundInfluentialWang, H., Chen, T., Wan, L., Lu, J., Wei, H., Deng, K., Wei, J., & Xin, H. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10485-3 · Cited by 20
Harnessing intratumoral microbiota: new horizons in immune microenvironment and immunotherapy
Zhang, J., You, Z., Li, X., Hu, J., Li, J., & Jing, Z. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06916-2 · Cited by 19
Zhao, L., Xin, J., Hu, M., Xue, C., & Dong, N. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.10.028 · Cited by 19
“Further innovations include cytokine engineering, by expressing the membrane-anchored Interleukin-15 (IL-15)/IL-2 fusion protein, attenuated Salmonella can activate tumor-infiltr ating lymphocytes (TILs) and expand the memory T cell population, forming a long-lasting immune surveillance [34].”
Engineered bacteria for cancer therapy: Advancements, challenges, and future directions
Wang, M.-G., Liu, M., Wang, D., Yang, D., Zeng, Y., Lan, Y., & Wang, Q. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003807 · Cited by 19
“[99] The activation of STING in phagocytic antigen-presenting cells (APCs) represents another promising strategy.”
Bacteria-mediated tumor immunotherapy via photothermally-programmed PD1 expression
Xu, W., Ren, D., Yu, Z., Hou, J., Huang, F., Gan, T., Ji, P., Zhang, C., Ma, L., & Hu, Y. (2022) · Nanoscale Advances · doi:10.1039/d1na00857a · Cited by 19
Mattiola, I., & Diefenbach, A. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101724 · Cited by 19
Lee, J., Im, K.-I., Gil, S., Na, H., Min, G. J., Kim, N., & Cho, S. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03679-5 · Cited by 19
Gut microbiota in cancer initiation, development and therapy
Zhang, R., Zhang, X., Lau, H. C.-H., & Yu, J. Q. (2024) · Science China Life Sciences · doi:10.1007/s11427-024-2831-x · Cited by 19
“Another engineered S . typhimurium strain secreting Vibrio vulnificus flagellin B within tumor tissues activated intra-tumoral M1 macrophages and reduced M2-like suppressive activities (Zheng et al., 2017).”
Prostate and urinary microbiomes in prostate cancer development: focus on Cutibacterium acnes
Fu, F., Yu, Y., Wang, B., Zhao, X., Wang, N., Yin, J., Wu, K., & Zhou, Q. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1562729 · Cited by 19
Cellular Bioparticulates with Therapeutics for Cancer Immunotherapy
Wang, C., Wen, D., & Gu, Z. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00619 · Cited by 19
Pangilinan, C. R., Wu, L.-H., & Lee, C. (2021) · Cancers · doi:10.3390/cancers13122894 · Cited by 19
“Furthermore, an engineered Salmonella typhimurium secreting heterologous flagellin B (FlaB) was found to induce phenotypic and functional activation of M1-like macrophages via TLR4 instead of TLR5, which is the commonly known receptor for the FlaB ligand, which in turn suppressed tumor growth and inhibited metastasis…”
BackgroundMackie, G. M., Copland, A., Takahashi, M., Nakanishi, Y., Everard, I., Kato, T., Oda, H., Kanaya, T., Ohno, H., & Maslowski, K. M. (2021) · JCI Insight · doi:10.1172/jci.insight.139900 · Cited by 19
Cell mass-dependent expression of an anticancer protein drug by tumor-targeted Salmonella
Kim, K., Min, S.-Y., Lim, H.-D., You, S.-H., Lim, D., Jeong, J., Kim, H., Rhee, J. H., Park, K., Shin, M., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24013 · Cited by 19
“Bacterial cancer therapy relies on the natural propensity of certain bacteria, including Escherichia coli [1], Salmonella [2], Clostridium [3], and Listeria [4], to accumulate and replicate in various types of tumors [5].”
BackgroundSelf-citationUncovering the role of the gut microbiota in immune checkpoint blockade therapy: A mini-review
Halsey, T. M., Ologun, G. O., Wargo, J. A., & Jenq, R. R. (2020) · Seminars in Hematology · doi:10.1053/j.seminhematol.2020.05.002 · Cited by 19
Zhou, P., Zhang, W., Liao, Y., Zhai, Z., Lu, S., Jiang, S., Hu, W., & Gong, W. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000002573 · Cited by 18
Self-citationMyeloid MyD88 restricts CD8+ T cell response to radiation therapy in pancreatic cancer
Medler, T. R., Blair, T. C., Alice, A. F., Dowdell, A. K., Piening, B., Crittenden, M. R., & Gough, M. J. (2023) · Scientific Reports · doi:10.1038/s41598-023-35834-w · Cited by 18
Metadata
- Authors
- Zheng, J. H., Nguyen, V. H., Jiang, S.-N., Park, S.-H., Tan, W., Hong, S. H., Shin, M. G., Chung, I.-J., Hong, Y., Bom, H.-S., Choy, H. E., Lee, S. E., Rhee, J. H., & Min, J.-J.
- Affiliations
- Chonnam National University (KR)
- City Of Hope National Medical Center (US)
- Department of Nuclear Medicine, Chonnam National University Medical School, Gwangju 61469, Republic of Korea.
- Korea Research Institute of Bioscience and Biotechnology (KR)
- Corresponding author
- Rhee, Joon Haeng
- Min, Jung-Joon
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2017-02-08
- Volume
- 9
- Issue
- 376
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2586223583
- Cited by
- 588
- References
- 54
- Citations by year
- 2026: 76 · 2025: 81 · 2024: 85 · 2023: 73 · 2022: 71 · 2021: 65 · 2020: 55 · 2019: 34 · 2018: 30 · 2017: 18
- FWCI
- 27.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- KRIBB Repository (submittedVersion)
- Funders
- Pioneer Research Center Program (2015M3C1A3056410)
- Bio & Medical Technology Development Program (NRF-2014M3A9B5073747)
- National Research Foundation of Korea
- Ministry of Science, ICT and Future Planning
- NRF (2012-0006072)
- Ministry of Health and Welfare, Republic of Korea (HI14C0187)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- cancer immunotherapy, Salmonella typhimurium, tumor-targeting bacteria, intratumoral macrophages, M1 macrophage polarization, TLR ligands
- MeSH terms
- Animals, Colonic Neoplasms, Flagellin, Genetic Engineering, Humans, Immunotherapy, Macrophages, Male, Mice, Inbred C57BL, Mice, Nude, Neoplasm Metastasis, Neoplasms, Phenotype, Salmonella typhimurium, Colony Count, Microbial, Signal Transduction, Cell Polarity, Xenograft Model Antitumor Assays, HCT116 Cells, Toll-Like Receptor 5
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.